AstraZeneca and lung cancer: the pharmaphorum podcast

This episode of the pharmaphorum podcast focuses on lung cancer, with AstraZeneca’s VP, Global Franchise Head, Tagrisso TDR (Tumour Drivers and Resistance) Patrick Connor explaining why the disease should be a priority for society.

He also discussed the changes he hopes to see in lung cancer and where AstraZeneca’s oncology business is headed, the pharma company’s work on biomarkers and where companion diagnostics fit into its work.

Episode 14 of the pharmaphorum podcast is a companion piece to our previous instalment, which heard from AstraZeneca’s Paul Naish about the quality of online information available for lung cancer patients.

You can listen to episode 14 of the pharmaphorum podcast in the player below, download the episode to your computer or find it – and subscribe to the rest of the series – in iTunes, Spotify, acast and Stitcher.

AstraZeneca and lung cancer: the pharmaphorum podcast

 
 
00:00 / 21:49
 
1X